Manabu Inoue: Tenecteplase or Alteplase Before Thrombectomy by T-FLAVOR Trial
Manabu Inoue, Chief Medical Officer at Pharmaceuticals and Medical Devices Agency (PMDA), shared on LinkedIn about a recent article he and his colleagues co-authored, published in JAMA Neurology, adding:
”I am pleased to share that the T-FLAVOR trial has been published in JAMA Neurology.
T-FLAVOR is a multicenter, randomized clinical trial comparing tenecteplase with the approved Japanese low-dose alteplase (0.6 mg/kg) before endovascular thrombectomy in patients with acute ischemic stroke.
To our knowledge, this is the first randomized trial to evaluate these two thrombolytic strategies in Japan.
I am sincerely grateful to all investigators, study coordinators, patients, and their families for making this study possible.
I hope these findings will contribute to improving stroke care and advancing evidence-based treatment worldwide.”
Title: Standard-Dose Tenecteplase vs Low-Dose Alteplase for Acute Ischemic Stroke From Large-Vessel Occlusion. A Randomized Clinical Trial
Authors: Manabu Inoue, Teruyuki Hirano, Mayumi Fukuda-Doi, Hiroyuki Kawano, Kenta Tanaka, Nobuyuki Sakai, Masatoshi Koga, Koji Iwasaki, Tomohide Yoshie, Naruhiko Kamogawa, Masafumi Ihara, Tsuyoshi Ohta, Masaki Chin, Naoto Kimura, Kazumi Kimura, Yohei Tateishi, Tadashi Terasaki, Taketo Hatano, Takahiro Kuwashiro, Shinichi Yoshimura, Toshihiro Ueda, Eiichiro Nagata, Yoshinari Nagakane, Shinichi Takahashi, Fumio Miyashita, Kazutaka Sonoda, Kenji Fukuda, Kanta Tanaka, Yoshiko Une, Shigetaka Kobari, Takehiko Nagao, Makoto Sasaki, Haruko Yamamoto, Kazunori Toyoda for the T-FLAVOR trial Investigators
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 10:32Natalie Arnold: The Lp(a) Puzzle – Why Lower Levels May Not Tell the Whole Story
-
Nov 9, 2026, 10:22ISBT Opens Applications for the I TRY IT Programme 2027
-
Nov 9, 2026, 10:08Ibrahim Mansoor: Rare Tests, Common Diseases – Rethinking Autoimmune Diagnostics
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services